Atossa Therapeutics Inc (NASDAQ:ATOS)

1.51
Delayed Data
As of Apr 19
 -0.12 / -7.36%
Today’s Change
0.81
Today|||52-Week Range
5.08
+58.95%
Year-to-Date

Stock Price Forecast

The 2 analysts offering 12-month price forecasts for Atossa Therapeutics Inc have a median target of 6.38, with a high estimate of 7.75 and a low estimate of 5.00. The median estimate represents a +322.19% increase from the last price of 1.51.

Analyst Recommendations

The current consensus among 2 polled investment analysts is to Buy stock in Atossa Therapeutics Inc. This rating has held steady since April, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.05
Sales
$0.00
Reporting Date
May 18

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 94.32%
 
 
 
 
 
 
Growthannually 90.36%
 
 
 
 
 
 

Sales

Growthquarterly --
Growthannually --
Key to the earnings and sales forecast charts.